AZZALURE

This brand name is authorized in Austria, Croatia, Finland, France, Ireland, Malta, Netherlands, Poland, Spain, UK.

Active ingredients

The drug AZZALURE contains one active pharmaceutical ingredient (API):

1	Botulinum toxin type A UNII E211KPY694 - BOTULINUM TOXIN TYPE A
	Botulinum toxin type A is a protein complex derived from Clostridium botulinum. The protein consists of type A neurotoxin and several other proteins. Under physiological conditions it is presumed that the complex dissociates and releases the pure neurotoxin. Intramuscular injection of the neurotoxin complex blocks cholinergic transport at the neuromuscular junction by preventing the release of acetylcholine. The nerve endings of the neuromuscular junction no longer respond to nerve impulses and secretion of the chemotransmitter is prevented (chemical denervation).
	Read more about Botulinum toxin type A

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AZZALURE Powder for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03AX01	Botulinum toxin	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AX Other muscle relaxants, peripherally acting agents
Discover more medicines within M03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	71300
FI	Lääkealan turvallisuus- ja kehittämiskeskus	044170, 483062
FR	Base de données publique des médicaments	66865211
GB	Medicines & Healthcare Products Regulatory Agency	156566, 226853
HR	Agencija za lijekove i medicinske proizvode	HR-H-020838433
MT	Medicines Authority	MA870/00101
NL	Z-Index G-Standaard	15569608
NL	Z-Index G-Standaard, PRK	92592
PL	Rejestru Produktów Leczniczych	100222105